Discover how Butorphanol, a common opioid painkiller, shows promising anti-cancer effects against ovarian cancer by targeting the TMEFF1 gene and AKT/mTOR pathway.
Exploring how microRNAs are revolutionizing our understanding of serous ovarian carcinoma and opening new avenues for diagnosis and therapy.